|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities (at fair value) | ||||||||||||||||||||
| Mortgages receivable | ||||||||||||||||||||
| Loans held for investment (net of deferred loan fees of $1,753 and $2,230) | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Total loans held for investment (net of deferred loan fees of $1,753 and $2,230) | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Total allowance for credit losses | ||||||||||||||||||||
| Loans held for investments, net of allowances for credit losses | ||||||||||||||||||||
| Loans held for investment, net | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Total loans held for investment, net | ||||||||||||||||||||
| Investments in rental real estate, net | ||||||||||||||||||||
| Loans held for sale (net of valuation allowance of $4,876 and $4,880) | ||||||||||||||||||||
| Loans held for sale (net of valuation allowance of $- and $4,880, respectively) | ||||||||||||||||||||
| Interest and fees receivable (net of allowance of $2,915 and $3,133) | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Due from borrowers (net of allowance of $906 and $1,135) | ||||||||||||||||||||
| Real estate owned (net of impairment of $185 and $492) | ||||||||||||||||||||
| Investments in partnerships | ||||||||||||||||||||
| Investments in limited liability companies | ||||||||||||||||||||
| Investments in developmental real estate, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Notes payable (net of deferred financing costs of $1,213 and $1,905) | ||||||||||||||||||||
| Senior secured notes payable (net of deferred financing costs of $3,152 and $3,427) | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Mortgage payable | ||||||||||||||||||||
| Lines of credit | ||||||||||||||||||||
| Accrued dividends payable | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Advances from borrowers | ||||||||||||||||||||
| Below market lease intangible | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Other notes | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred shares - $0.001 par value; 5,000,000 shares authorized; 3,332,000 shares designated as Series A Preferred Stock; 2,312,758 shares of Series A Preferred Stock issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common Shares - $0.001 par value; 200,000,000 shares authorized; 47,954,632 and 47,684,955 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Cumulative net earnings | ||||||||||||||||||||
| Cumulative dividends paid | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
